PyInvesting

Market research

NPW1.F Smith & Nephew plc

F EUR Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
10B
P/E ratio
19.52
Analyst target
Not available
Dividend yield
3.2%
Beta
0.68

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Smith & Nephew plc is currently in a long term uptrend where the price is trading 8.9% above its 200 day moving average.

From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.6.

Smith & Nephew plc's total revenue sank by 0.0% to $1B since the same quarter in the previous year.

Its net income has dropped by 0.0% to $146M since the same quarter in the previous year.

Finally, its free cash flow grew by 31.4% to $304M since the same quarter in the previous year.

Based on the above factors, Smith & Nephew plc gets an overall score of 3/5.